Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Avg
|
|
New words:
abatement, abide, Academy, Actel, Adjunct, advice, advisory, affiliate, affiliated, affirmatively, Affymax, amino, Andersen, anniversary, Antitrust, Apple, appointed, appointment, appraisal, Argonaut, Arthur, attaining, attainment, attendance, attended, Australian, automobile, Axoclamp, BCM, Becton, benchmarking, Berkeley, Biochemistry, Biomedical, bioscience, Black, Brazil, Brown, Bruker, Budget, CA, Cal, Canberra, CapSure, car, Cardiff, Care, Cellmark, Cepheid, chair, chairperson, Chapter, chosen, classification, clean, clock, club, COBRA, column, commensurate, communicated, community, composed, Comptronix, Computershare, conflict, consent, constructive, contemplated, context, converted, coordination, counsel, culminated, Curtin, customary, cutting, Davenport, death, Debeye, dedicated, delegate, dental, derecognition, descent, desirability, deter, detract, Dickinson, diligently, Dionex, disability, discernable, disclaim, discretion, discretionary, disregarding, dissolution, division, DNAX, doctorate, documentary, Dr, Drew, driver, Drs, DTD, Electromer, embodying, employment, enterprise, EPS, Equilar, EquiServe, erode, excise, explicit, extract, factor, Fast, Fellow, Fisher, Florida, footnote, formal, fostering, founder, Franklin, FRI, Georgia, Gillian, golden, governmental, Graduate, hand, Harvard, Hill, holder, HTRF, Hunter, IIe, iii, Illumina, Immunocytometry, implied, incentivize, inception, inconsistent, inflow, infrared, input, instance, interlocking, inverted, involuntarily, Irrevocable, Jan, Jane, job, John, Johnson, joined, joining, joint, Jose, Jr, Junior, knowledge, LCM, leadership, leave, led, LEICA, letter, lieu, lifetime, lump, MDS, Mechanical, Medal, membership, Meta, Micrel, Microbiology, microdissection, Millipore, misconduct, mitigate, momentum, Monash, Montgomery, Monument, multinational, Murray, NA, negotiated, noncompetition, noncompliance, nonpublic, OFI, open, opening, Oppenheimer, optionholder, Orchid, ordinarily, Oregon, organizational, outflow, outlined, overhead, owner, parachute, partner, Partnership, Patricia, pecuniary, peer, pension, permissible, perquisite, PerSeptive, pertinent, Peter, philosophy, phone, Physical, physician, PixCell, plc, Poly, precision, preliminary, premier, presence, Prize, producing, Professor, promulgated, properly, purest, pursue, pursuing, QBT, Queensland, reclassify, recommendation, recommended, recommending, Reconciliation, reevaluated, rejecting, relationship, reluctance, reluctant, remuneration, restrain, retrieval, reversal, reverse, Revocable, reward, Richard, RNA, Robert, Royal, Rupert, satisfaction, School, science, scientist, Scorecard, secretarial, Shanghai, Sharp, Silicon, smallest, Society, Sophia, Specialty, Sportsman, spouse, StakMax, Stanford, Steven, Stratagene, strike, structured, sum, Surgery, Sutter, Swain, talented, Techne, teleconference, Telik, tenancy, tender, tendered, tenure, Terrapin, thereunder, tissue, tool, transferee, travel, Trevor, Trust, trustee, UAD, ultraviolet, unveil, upstream, validly, venture, VeritasTM, vision, Vivra, waiting, WCM, WEDGE, Welch, Wheland, Wicke, wider, withhold, withholding, Wolf, XTTM
Removed:
acquiring, amortizing, carried, credited, Cytion, discontinued, Electron, EMax, environment, extend, handle, limitation, marketable, mature, MetaFluor, nonqualified, paul, Proposal, purport, Ratification, redeemable, representative, settlement, solicitation, spent, undiscounted, utilization, VMax
Filing tables
Filing exhibits
Related press release
MDCC similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-4318, 333-86155, 333-86159, 333-45288, 333-63036, 333-91996, 333-106698, and 333-117133) of Molecular Devices Corporation of our reports dated March 15, 2007, with respect to the consolidated financial statements and schedule of Molecular Devices Corporation, Molecular Devices Corporation management’s assessment of the effectiveness of internal control over financial reporting and the effectiveness of internal control over financial reporting of Molecular Devices Corporation, included in this Annual Report (Form 10-K) for the year ended December 31, 2006.
/s/ Ernst & Young LLP
Palo Alto, California
March 15, 2007
March 15, 2007